Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00333255
Status:
COMPLETED
Last Update Posted:
2009-07-08
First Post:
2006-06-01
Brief Title:
Nepafenac Opthalmic Suspension 01 Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
Sponsor:
Alcon Research
Organization:
Alcon Research
Study Overview
Official Title:
Preoperative and Postoperative Nevanac 01 Compared to Acular LS for the Treatment of Ocular Inflammation Associated With Cataract Surgery
Status:
COMPLETED
Status Verified Date:
2009-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension 01 eye drops to Acular LS eye drops used before and after cataract surgery for treating inflammation in the eye
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None